Scholar Rock Holding (SRRK) Other Non-Current Liabilities (2017 - 2021)
Scholar Rock Holding (SRRK) recorded quarterly Other Non-Current Liabilities of $3000.0 in Q2 2021, down 25.0% quarter-over-quarter from $4000.0 in Q1 2021.
Scholar Rock Holding (SRRK) Other Non-Current Liabilities (2017 - 2021) Analysis & Trends
Scholar Rock Holding's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $3000.0 for Q2 2021.
- In Q2 2021, Other Non-Current Liabilities changed N/A year-over-year to $3000.0; the TTM figure through Jun 2021 stood at $3000.0 (changed N/A YoY), while the FY2020 annual figure was $5000.0, down 44.44% from the prior year.
- Other Non-Current Liabilities was $3000.0 for Q2 2021 at Scholar Rock Holding, down from $4000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $37000.0 in Q4 2017 to a low of $3000.0 in Q2 2021.
- Historically, Other Non-Current Liabilities has averaged $11600.0 across 4 years, with a median of $5000.0 in 2020.
- Biggest YoY gain for Other Non-Current Liabilities was 44.44% in 2020; the steepest drop was 44.44% in 2020.
- A 4-year view of Other Non-Current Liabilities shows it stood at $37000.0 in 2017, then plunged by 75.68% to $9000.0 in 2019, then slumped by 44.44% to $5000.0 in 2020, then slumped by 40.0% to $3000.0 in 2021.
- The last three Other Non-Current Liabilities figures came in at $3000.0 (Q2 2021), $4000.0 (Q1 2021), and $5000.0 (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Dec 31, 2017 | 37,000.00 |